| TCVAX | VMVAX | TCVAX / VMVAX | |
| Total Expense Ratio | 1.17 | 0.07 | 1,671% |
| Annual Report Gross Expense Ratio | 1.36 | 0.07 | 1,943% |
| Fund Existence | 17 years | 15 years | - |
| Gain YTD | 14.388 | 10.440 | 138% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 566M | 36.6B | 2% |
| Annual Yield % from dividends | 0.75 | 1.88 | 40% |
| Returns for 1 year | 21.99 | 21.29 | 103% |
| Returns for 3 years | 31.94 | 43.43 | 74% |
| Returns for 5 years | 19.92 | 43.85 | 45% |
| Returns for 10 years | 68.54 | 125.61 | 55% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AFOZX | 23.13 | 0.16 | +0.70% |
| Alger Mid Cap Focus Z | |||
| IRGJX | 46.56 | -0.50 | -1.06% |
| Voya Russell Mid Cap Growth Idx Port I | |||
| PCUZX | 74.54 | -0.83 | -1.10% |
| T. Rowe Price U.S. Equity Research Z | |||
| TDEIX | 35.78 | -0.47 | -1.30% |
| Transamerica US Growth I | |||
| AFDZX | 26.08 | -0.35 | -1.32% |
| Applied Finance Explorer Institutional | |||